The PCR-invader method (structure-specific 5 nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; Comparison with direct sequencing

International Journal of Clinical Oncology

Volumn 16, Issue 4, 2011, Pages 335-344

  Naoki, Katsuhiko ^a   Soejima, Kenzo ^a   Okamoto, Hiroaki ^b   Hamamoto, Junko ^a   Hida, Naoya ^b   Nakachi, Ichiro ^a   Yasuda, Hiroyuki ^a   Nakayama, Sohei ^a   Yoda, Satoshi ^a   Satomi, Ryosuke ^a   Ikemura, Shinnosuke ^a   Terai, Hideki ^a   Sato, Takashi ^a   Watanabe, Koshiro ^b  

^a KEIO UNIVERSITY   (Japan)

^b YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

Author keywords

Direct sequencing; EGFR mutation; Gefitinib; Non small cell lung cancer; PCR invader method; Validation

Indexed keywords

GEFITINIB; VASCULOTROPIN;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; EGFR GENE; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MALE; ONCOGENE; PERICARDIAL EFFUSION; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYRIBONUCLEASES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 80052711711     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0187-5     Document Type: Article

References (30)

1. L Ding G Getz DA Wheeler, et al. 2008 Somatic mutations affect key pathways in lung adenocarcinoma Nature 455 1069 1075 18948947 10.1038/nature07423 1:CAS:528:DC%2BD1cXht1yju73J
2. K Naoki TH Chen WG Richards, et al. 2002 Missense mutations of the BRAF gene in human lung adenocarcinoma Cancer Res 62 7001 7003 12460919 1:CAS:528:DC%2BD38XpsVahsbs%3D (Pubitemid 35424093)
3. JG Paez PA Jänne JC Lee, et al. 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 1497 1500 15118125 10.1126/science.1099314 1:CAS:528:DC%2BD2cXksVGmsbs%3D (Pubitemid 38720929)
4. TJ Lynch DW Bell R Sordella, et al. 2004 Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib New Engl J Med 350 2129 2139 15118073 10.1056/NEJMoa040938 1:CAS:528:DC%2BD2cXktF2js7c%3D (Pubitemid 38637993)
5. TS Mok YL Wu S Thongprasert, et al. 2009 Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma New Engl J Med 361 947 957 19692680 10.1056/NEJMoa0810699 1:CAS:528:DC%2BD1MXhtVygsbfK
6. R Rosell T Moran C Queralt, et al. 2009 Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 958 967 19692684 10.1056/NEJMoa0904554 1:CAS:528:DC%2BD1MXhtVOqsL7M
7. T Takano Y Ohe K Tsuta, et al. 2007 Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non-small-cell lung cancer treated with gefitinib Clin Cancer Res 13 5385 5390 17875767 10.1158/1078-0432.CCR-07-0627 1:CAS:528:DC%2BD2sXhtVCitLzN (Pubitemid 47510364)
8. I Kawada K Soejima H Watanabe, et al. 2008 An alternative method for screening EGFR mutation using RFLP in non-small-cell lung cancer patients J Thorac Oncol 3 1096 1103 18827604 10.1097/JTO.0b013e318186fadd
9. H Kimura Y Fujiwara T Sone, et al. 2006 High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small-cell lung cancer patients Cancer Sci 97 642 648 16827805 10.1111/j.1349-7006.2006.00216.x 1:CAS:528:DC%2BD28XmsVOntLs%3D (Pubitemid 44056613)
10. Nagai Y, Miyazawa H, Huqun et al (2005) Genetic heterogeneity of the epidermal growth factor receptor in non-small-cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65:7276-7282 (Pubitemid 41161259)
11. Yasuda H, Soejima K, Nakayama S et al (2010) Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer. Lung Cancer Aug 31 [Epub ahead of print]
12. DA Eberhard G Giaccone BE Johnson 2008 Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting J Clin Oncol 26 983 994 18281673 10.1200/JCO.2007.12.9858 (Pubitemid 351398092)
13. ® assay for SNP genotyping Mutat Res 573 103 110 15829241 1:CAS:528:DC%2BD2MXjt1Wjurk%3D
14. V Lyamichev AL Mast JG Hall, et al. 1999 Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes Nat Biotechnol 17 292 296 10096299 10.1038/7044 1:CAS:528: DyaK1MXhs1Chu7c%3D (Pubitemid 29122638)
15. JG Hall PS Eis SM Law, et al. 2000 Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction Proc Natl Acad Sci USA 97 8272 8277 10890904 10.1073/pnas.140225597 1:CAS:528: DC%2BD3cXlt1Ggt7k%3D (Pubitemid 30639662)
16. Y Mashima M Nagano T Funayama, et al. 2004 Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the Invader technology Clin Biochem 37 268 276 15003728 10.1016/j.clinbiochem.2003.11.011 1:CAS:528:DC%2BD2cXhslWmtLY%3D (Pubitemid 38314880)
17. K Tadokoro M Kobayashi T Yamaguchi, et al. 2006 Classification of hepatitis B virus genotypes by the PCR-invader method with genotype-specific probes J Virol Methods 138 1-2 30 39 16934340 10.1016/j.jviromet.2006.07.014 1:CAS:528:DC%2BD28XhtFeqtLfO (Pubitemid 44633445)
18. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D (Pubitemid 30099779)
19. I Nakachi K Naoki K Soejima, et al. 2010 The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition Mol Cancer Res 8 1142 1151 20647329 10.1158/1541-7786.MCR-09-0388 1:CAS:528:DC%2BC3cXhtVanu7%2FF
20. A Inoue T Suzuki T Fukuhara, et al. 2006 Prospective phase II study of gefitinib for chemotherapy-naïve patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations J Clin Oncol 24 3340 3346 16785471 10.1200/JCO.2005.05.4692 1:CAS:528:DC%2BD28Xot1Kis7g%3D (Pubitemid 46638887)
21. K Yoshida Y Yatabe JY Park, et al. 2007 Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in non-small-cell lung cancer J Thorac Oncol 2 22 28 17410005 10.1097/01243894-200701000-00006 (Pubitemid 47163924)
22. N Sunaga Y Tomizawa N Yanagitani, et al. 2007 Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small-cell lung cancer with EGFR mutations, irrespective of previous chemotherapy Lung Cancer 56 383 392 17368623 10.1016/j.lungcan.2007.01.025 (Pubitemid 46679091)
23. H Asahina K Yamazaki I Kinoshita, et al. 2006 A phase II trial of gefitinib as first-line therapy for advanced non-small-cell lung cancer with epidermal growth factor receptor mutations Br J Cancer 95 998 1004 17047648 10.1038/sj.bjc.6603393 1:CAS:528:DC%2BD28XhtVyitbfO (Pubitemid 44606825)
24. A Sutani Y Nagai K Udagawa, et al. 2006 Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locking nucleic acid PCR clamp Br J Cancer 95 1483 1489 17106442 10.1038/sj.bjc.6603466 1:CAS:528:DC%2BD28Xht1Cntr3J (Pubitemid 44863350)
25. K Tamura I Okamoto T Kashii, et al. 2008 Multicentre prospective phase II trial of gefitinib for advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) Br J Cancer 98 907 914 18283321 10.1038/sj.bjc.6604249 1:CAS:528:DC%2BD1cXivVOgtbo%3D (Pubitemid 351341609)
26. B Thyagarajan KE Anderson F Kong, et al. 2005 New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women's health study J Clin Pathol 58 955 961 16126877 10.1136/jcp.2004. 023374 1:CAS:528:DC%2BD2MXhtFSks7fE (Pubitemid 41265281)
27. H Greulich TH Chen W Feng, et al. 2005 Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants PLoS Med 2 e313 16187797 10.1371/journal.pmed.0020313 (Pubitemid 41735785)
28. T Mitsudomi Y Yatabe 2007 Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer Cancer Sci 98 1817 1824 17888036 10.1111/j.1349-7006.2007.00607.x 1:CAS:528:DC%2BD2sXhsVahtbbF (Pubitemid 350002184)
29. T Mitsudomi S Morita Y Yatabe, et al. 2010 Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Lancet Oncol 11 121 128 20022809 10.1016/S1470-2045(09)70364-X 1:CAS:528:DC%2BC3cXhtlGgtbo%3D
30. M Maemondo A Inoue K Kobayashi, et al. 2010 Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2380 2388 20573926 10.1056/NEJMoa0909530 1:CAS:528:DC%2BC3cXot1Gjt7Y%3D